过敏支气管肺性阿斯伯吉洛斯症呈现为肺肺胸部:扩大临床范围
Jitendra Kumar Saini1, Yasir V Abdullah2, Shibani Modi3
1Department of Thoracic Oncology, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
Annals of African medicine
|December 1, 2025
概括
过敏性支气管肺性阿斯伯吉洛症 (ABPA) 在喘患者中可以呈现为pyo-pneumothorax. 早期诊断和联合皮质类固醇抗真菌治疗对于这种罕见的并发症的良好结果至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 过敏和免疫学 过敏和免疫学
- 传染性疾病 传染性疾病
背景情况:
- 过敏性支气管肺性阿斯伯吉洛症 (ABPA) 是一种对Aspergillus fumigatus的过敏反应.
- 在ABPA中,多参与是罕见的,而pyo-pneumothorax是一个非常不常见的表现.
研究的目的:
- 报告一个罕见的ABPA病例与pyo-pneumothorax一起出现.
- 突出承认脏参与ABPA管理的重要性.
主要方法:
- 一个23岁的喘女性的病例报告.
- 诊断标准包括IgE升高,针对A. fumigatus的特定IgE/IgG抗体,以及成像发现.
- 治疗涉及系统性皮质类固醇和伊特拉可纳.
主要成果:
- 该患者出现了pyo-pneumothorax,支气管阻塞的粘液塞,和支气管支气管.
- 显著增加的IgE水平和阳性A. fumigatus抗体证实了ABPA.
- 治疗导致显著的症状和放射性改善.
结论:
- 肌肺胸部是ABPA的一个潜在的,尽管很少见的表现.
- 早期识别和多学科管理对于预防发病至关重要.
- 临床医生应考虑在患有肺部疾病,IgE升高和支气管支障碍的喘患者中使用ABPA.
相关概念视频
01:27Pneumothorax-II
856
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
856
01:26Pneumothorax-I
1.1K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.1K
01:17Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
01:29Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
01:30Pneumonia I: Introduction
702
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
702
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K